Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?
Bacterial adaptation occurred when lactose intolerant subjects ingested lactose for 13 days, and all symptoms except diarrhoea regressed. Clinical improvement was also observed in the control group which displayed no signs of metabolic adaptation. This suggests that improved clinical tolerance may be just a placebo effect.
Our results show that calcified plaque is common in ESRD patients and hypoalbuminaemia may be an associated factor.